Written by the Nuvirox Research Team
Key points
- Polypharmacy, commonly defined as taking five or more regular medications, is associated with a meaningfully higher risk of frailty and fatigue-related symptoms in older adults — one study found each additional medication raised frailty risk by about 30%.
- The fatigue usually isn't from the raw pill count itself but from a specific, identifiable subset of drugs — anticholinergics, sedatives, and certain muscle relaxants or antidepressants — whose effects stack when taken together and are amplified by age-related changes in drug clearance.
- Deprescribing trials show medication burden can be reduced safely under medical supervision, but the evidence for reliably fixing fatigue specifically, as opposed to reducing pill counts, is more mixed than marketing around "medication reviews" usually implies.
Short answer: often yes, with an important caveat — it's rarely the number of pills itself, but which ones and how they interact. The fair reading of the geriatric-medicine literature is that polypharmacy is a genuine, well-documented contributor to unexplained fatigue in older adults, largely because certain drug classes (sedatives, anticholinergics, some antidepressants and muscle relaxants) have effects that add up, and because aging kidneys and livers clear drugs more slowly, so effective doses can drift upward even when prescriptions haven't changed.
This is worth taking seriously precisely because it's fixable in a way many causes of late-life fatigue aren't — but it also shouldn't be assumed without a proper medication review, since stopping medications without medical guidance carries its own risks. Here's what the research on medication burden, deprescribing, and fatigue actually shows.
How Can Taking Multiple Medications Combine to Cause Fatigue?
Through three compounding mechanisms. First, additive sedation: many common medications for sleep, allergies, pain, bladder control, and mood have some sedating effect individually, and those effects don't simply average out when combined — they stack. Second, cumulative anticholinergic burden: a wide range of drug classes (certain antihistamines, some bladder medications, some antidepressants, some muscle relaxants) block acetylcholine to varying degrees, and their combined "anticholinergic burden" is linked in the literature to fatigue, cognitive slowing, and falls, even when no single drug on the list looks concerning by itself. Third, and often overlooked, aging changes how the body processes drugs: reduced kidney filtration and liver metabolism mean the same dose that was well-tolerated at 55 can produce meaningfully higher blood levels at 75, amplifying every one of the above effects.
Drug-drug interactions add a further layer: two medications that are individually safe can compete for the same liver enzymes, slowing the clearance of one or both and pushing effective drug levels higher than either prescription alone would suggest.
How Many Medications Actually Counts as Polypharmacy?
Most of the research literature defines polypharmacy as five or more regularly taken medications, with "hyperpolypharmacy" used for ten or more. But the count is a proxy, not the mechanism — a 2023 cross-sectional study using data from the Midlife in the United States (MIDUS) project, involving 328 community-dwelling adults aged 65–85, found a clear dose-response relationship: each additional medication was associated with roughly a 30% increase in the odds of frailty, and participants on five or more medications had nearly five times the odds of frailty compared with those on fewer. The same analysis found that six or more medications distinguished frail from non-frail participants reasonably well (fair to moderate accuracy). Frailty and fatigue are closely linked constructs in the geriatric literature, which is why medication count tracks so consistently with how "worn down" people report feeling, even though the count itself isn't the direct cause.
What Human Studies Actually Show
The MIDUS cross-sectional analysis (2023, Frontiers in Public Health, n=328) described above is useful for establishing the association between medication count and frailty, but it's observational: it can't prove that reducing medications reverses frailty or fatigue, only that they travel together. That's an important distinction the article itself is careful about, and one that matters for how much weight to put on medication count alone.
A randomized controlled trial published in the Journals of Gerontology: Series A (2023) tested exactly the intervention side of this question: deprescribing anticholinergic and sedative drugs in frail, community-dwelling older adults. The trial demonstrated that a structured, supervised deprescribing process could meaningfully and safely reduce anticholinergic and sedative medication burden in this population without an increase in adverse outcomes — direct evidence that reducing this specific drug burden is achievable under proper medical supervision, not just theoretically desirable.
A systematic review and meta-analysis in the Journal of the American Medical Directors Association (2023) pooled multiple randomized controlled trials of deprescribing interventions in older adults. This is the honest counterweight in this article: deprescribing trials as a group have been more consistent in demonstrating reductions in medication counts and inappropriate prescribing than in demonstrating reliable improvements in patient-reported outcomes like fatigue or quality of life across every included trial. In other words, the intervention clearly can reduce the pill burden that theory says should help fatigue, but not every trial captured a matching, statistically clean improvement in how patients actually felt day to day — a reminder that "fewer pills" and "more energy" don't automatically move in lockstep in every study, even when the underlying logic is sound.
What a Medication Review Won't Fix
Polypharmacy is unlikely to be the whole story if fatigue persists after a genuine medication review, or if it's accompanied by other specific findings that point elsewhere — anemia or low iron (see our piece on low iron without anemia), low vitamin B12 (see does low B12 cause fatigue), untreated sleep apnea, depression, thyroid dysfunction, or heart failure. Certain individual drug classes are worth flagging by name if you're on them and feeling drained: SNRIs (see our article on SNRI antidepressants and fatigue), the muscle relaxant cyclobenzaprine (see why cyclobenzaprine causes drowsiness), and the overactive-bladder medication oxybutynin (see oxybutynin's fatigue and cognitive effects) are each independently associated with sedation, and combining any two or more compounds the risk.
See a doctor promptly, rather than adjusting medications yourself, if fatigue is new or rapidly worsening, if it's accompanied by confusion, falls, chest pain, or shortness of breath, or if you're considering stopping any medication — some drugs (certain blood pressure medications, benzodiazepines, some antidepressants) carry real risks, including rebound effects or withdrawal symptoms, if stopped abruptly without a tapering plan.
What a Safe Deprescribing Timeline Looks Like
The deprescribing trials in this space describe a gradual, supervised process rather than an abrupt one: a comprehensive medication review (often using structured tools that flag anticholinergic and sedative burden specifically), followed by tapering one medication at a time, typically over weeks per medication, with follow-up to monitor for withdrawal effects or return of the original symptom the drug was treating. The randomized trial referenced above followed this kind of structured process in frail community-dwelling adults and found it could be carried out safely.
Trials in this area commonly follow patients for six to twelve months to assess whether medication reductions hold and whether meaningful symptom or functional improvements follow — which is also a realistic timeframe to expect for noticing whether your own energy actually improves after a review, rather than expecting an immediate change within days.
Frequently Asked Questions
Is it safe to just stop some of my medications if I think they're making me tired?
No — several medication classes (certain blood pressure drugs, benzodiazepines, some antidepressants) can cause withdrawal effects or a rebound of the original condition if stopped abruptly. Any change should go through your prescriber or a pharmacist-led medication review.
Which medications are most often linked to fatigue in older adults?
Sedatives and sleep aids, many antihistamines (especially older, first-generation ones), certain antidepressants, muscle relaxants like cyclobenzaprine, and some bladder medications like oxybutynin are the classes most consistently flagged in the anticholinergic- and sedative-burden literature.
How many medications is actually "too many"?
Most research uses five or more regular medications as the threshold for polypharmacy, with ten or more termed hyperpolypharmacy, but the more useful question is whether any of your specific medications carry sedative or anticholinergic effects, since two overlapping drugs from that category matter more than five unrelated ones.
Will a medication review actually make me feel less tired?
It's a reasonable and evidence-supported thing to try, and it reliably reduces medication burden and inappropriate prescribing when done properly — but the trial evidence for guaranteed fatigue or quality-of-life improvement in every case is more mixed than more categorical claims you may see elsewhere, so think of it as a worthwhile step, not a guaranteed fix.
FROM NUVIROX
Why We Formulated NAD+ Restore
Fatigue in later life often has several contributors layered together, and untangling medication effects from age-related changes in cellular energy metabolism isn't always straightforward. We formulated NAD+ Restore to support the cellular energy pathways that naturally become less efficient with age, as a general complement to — never a substitute for — a proper medication review with your doctor or pharmacist. It's backed by our 60-day money-back guarantee, long enough to actually evaluate it the way the research on this topic suggests you should.
Learn more about NAD+ Restore →The Bottom Line
Polypharmacy is a well-supported, genuinely fixable contributor to fatigue in many older adults, but the mechanism runs through specific drug classes and their additive sedative or anticholinergic effects, not simply through the number of pills in the organizer. If you or someone you're caring for takes five or more regular medications and feels persistently drained, a structured medication review with a doctor or pharmacist — not a self-directed cutback — is the evidence-backed next step, understood as one piece of a broader fatigue workup rather than a guaranteed single answer.
References
- Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2023;78(9):1698–1706. PMID: 36692224.
- Deprescribing interventions for older patients: a systematic review and meta-analysis. J Am Med Dir Assoc. 2023;24(11):1718–1725. PMID: 37582482.
- Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study. Front Public Health. 2023;11:1148671. DOI: 10.3389/fpubh.2023.1148671.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.